Cti Biopharma Corp logo

Cti Biopharma Corp Share Price (NASDAQ: CTIC)

▲

-9.09

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 23 Jun 2023

Check the interactive Cti Biopharma Corp Stock chart to analyse performance

Cti Biopharma Corp Key Stats

Check Cti Biopharma Corp key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$9.09
Open
$9.1
Market Capitalization
$1.2B
Today's Volume
$11.4M
Revenue TTM
$75.8M
EBITDA
$-53.6M
Earnings Per Share (EPS)
$-0.54
Dividend Yield
0.0%
Profit Margin
-91.38%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1018.75%

Global Institutional Holdings in Cti Biopharma Corp

  • Name

    Holdings %

  • State Street Corporation

    9.43%

  • Rubric Capital Management LP

    6.80%

  • Bvf Inc

    6.68%

  • BlackRock Inc

    5.39%

  • Stonepine Capital Management Llc

    4.96%

  • Marshall Wace Asset Management Ltd

    4.52%

Analyst Recommendation on Cti Biopharma Corp Stock

Rating
Trend

Buy

    57%Buy

    42%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Cti Biopharma Corp(by analysts ranked 0 to 5 stars)

About Cti Biopharma Corp

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an an oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTI BioPharma Corp. has license and collaboration agreement with Teva Pharmaceutical Industries Ltd. and S*BIO Pte Ltd. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.
Organization
Cti Biopharma Corp
Employees
127
CEO
Dr. Adam R. Craig M.B.A., M.D., Ph.D.
Industry
Health Technology

Important FAQs about investing in CTIC Stock from India :

What is Cti Biopharma Corp share price today?

Cti Biopharma Corp share price today is as on at the close of the market. Cti Biopharma Corp share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Cti Biopharma Corp share?

Cti Biopharma Corp share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Cti Biopharma Corp stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Cti Biopharma Corp Stock (CTIC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cti Biopharma Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cti Biopharma Corp Shares .

What is the minimum amount required to buy Cti Biopharma Corp Stock (CTIC) from India?

Indian investors can start investing in Cti Biopharma Corp (CTIC) shares with as little as ₹88.3 or $1 (as of September 14, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹883.00 in Cti Biopharma Corp stock (as per the Rupee-Dollar exchange rate as on September 14, 2025). Learn more about fractional shares .

What are the returns that Cti Biopharma Corp has given to Indian investors in the last 5 years?

Cti Biopharma Corp stock has given 0.0% share price returns and 20.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?